• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

IDCases . Successful Management of COVID-19 Induced Acute Respiratory Distress Syndrome by Extracorporeal Membrane Oxygenation with 1-year follow-u

tetano

Editor, Senior Moderator
IDCases


. 2021 Sep 3;e01281.
doi: 10.1016/j.idcr.2021.e01281. Online ahead of print.
Successful Management of COVID-19 Induced Acute Respiratory Distress Syndrome by Extracorporeal Membrane Oxygenation with 1-year follow-up: A Case Report


Ko-Wei Chang[SUP] 1 [/SUP], Kuang-Tso Lee[SUP] 2 [/SUP], Yu-Lun Lo[SUP] 1 3 [/SUP], Han-Chung Hu[SUP] 1 3 [/SUP], Cheng-Ta Yang[SUP] 1 3 [/SUP], Shu-Min Lin[SUP] 1 3 [/SUP]



Affiliations

Abstract

Coronavirus 2019 (referred to as COVID-19) has infected millions of people throughout the world. This paper reports on a case of COVID-19-induced acute respiratory distress syndrome (ARDS) in which the patient was administered extracorporeal membrane oxygenation (ECMO) to deal with refractory hypoxia. The patient recovered from ARDS following ECMO treatment. In 1-year follow-up, the muscle weakness persisted, and the pulmonary vital capacity recovered sooner than diffusion capacity.

Keywords: COVID-19; acute respiratory distress syndrome; extracorporeal membrane oxygenation.
 
Back
Top Bottom